Larin 24 Fe Kit
Product Images NDC 16714-416

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Larin 24 Fe (NDC 16714-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

This text provides instructions for the administration of LARIN 24 Fe, a combination hormonal contraceptive. The instructions are provided for women who are not currently using hormonal contraception. The instructions provide details on the color of active and inactive tablets, when to take them, and how to switch to or from other forms of contraception. The text emphasizes the importance of following complete instructions on proper tablet usage.*

FDA Label Image

2 (Image 02)

This is a set of instructions for missed dosages of LARIN 24 Fe Tablets. It covers what to do when one, two or three or more consecutive active tablets are missed in Week 1, Week 2, Week 3, Week 4 or anytime when taking these oral contraceptive tablets. The instructions detail what needs to be done in each case and whether additional back-up contraception is necessary.*

FDA Label Image

3 (Image 03)

FDA Label Image

4 (Image 04)

FDA Label Image

5 (Image 05)

FDA Label Image

6 (Image 06)

The text describes a figure showing the average concentration of ethinyl estradiol in the plasma of healthy female volunteers after they were given norethindrone acetate and ethinyl estradiol tablets orally. The concentrations were measured at different time intervals both on day 1 and day 24. The figure shows the concentration in pg/mL on the y-axis and time in hours on the x-axis.*

FDA Label Image

7 (Image 07)

Table 3 shows a summary of the pharmacokinetics of Norethindrone and Ethinyl Estradiol in healthy female volunteers. The table presents the arithmetic mean for different pharmacokinetic parameters such as AUC, Tmax, Cmin, and plasma concentration. The table also reports the SHBG concentration, AUC (0-24h), and the coefficient of variation. The text mentions that the SHBG concentration reported is the pre-dose concentration.*

FDA Label Image

8 (Image 08)

This is a table showing the effectiveness of various methods of birth control. The first section shows the number of pregnancies per 100 women in one year - with fewer than 1 for the most effective methods, and up to 85 or more for less effective methods. The second section lists the types of birth control methods, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The third section highlights the most effective methods for preventing pregnancy.*

FDA Label Image

9 (Image 09)

This appears to be a section of instructions for birth control pills. The text includes information for users who start taking the pills either on a Sunday or on a different day of the week (Day-1 starters). It includes a label strip for the latter group to mark the starting day of their menstrual cycle. The text also mentions different colors of pills (pale yellow and brown) and provides a diagram labeled Figure A showing the direction to take the pills each week.*

FDA Label Image

10 (Image 10)

FDA Label Image

11 (Image 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.